Literature DB >> 11922699

Cytokine secretion by peripheral blood mononuclear cells in myasthenia gravis.

Hiroaki Yoshikawa1, Katsuaki Satoh, Yoshihiro Yasukawa, Masahito Yamada.   

Abstract

We studied spontaneous secretion of anti-acetylcholine receptor antibody (AChRAb), IgG and cytokines by peripheral blood mononuclear cells (PBMC) from 19 MG patients without therapy and 10 normal controls. IgG secretion was higher in the culture medium of MG than in that of normal controls. AChRAb secretion was correlated with IgG secretion in MG. Interleukin (IL)-2, IL-4, IL-5, IL-6, IL-10, IL-13, interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha secreted by PBMC from MG patients were not different from those produced by those from normal controls. IgG secretion was, however, correlated with the secretions of IL-5 and IL-6 in MG. Spontaneous B cell activation was suspected in patients with MG. Copyright 2002, Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922699     DOI: 10.1054/jocn.2001.1028

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.

Authors:  Yong Zhang; Xiuying Zhang; Yan Xia; Xiao Jia; Hao Li; Yanyan Zhang; Zhen Shao; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Chenghua Xiao; Deqin Geng; Yonghai Liu; Guiyun Cui; Ruiguo Dong; Xiaoyu Huang; Tingyan Yu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

2.  LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis.

Authors:  Li Liu; Huixue Zhang; Xiaoyu Lu; Lifang Li; Tianfeng Wang; Shuang Li; Xu Wang; Si Xu; Lei Li; Qian Li; Tingting Yi; Tao Wu; Zhimin Chen; Hongyu Gao; Jianjian Wang; Lihua Wang
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

3.  The effect of interleukin (IL)-21 and CD4+ CD25++ T cells on cytokine production of CD4+ responder T cells in patients with myasthenia gravis.

Authors:  M Alahgholi-Hajibehzad; H Durmuş; F Aysal; Y Gülşen-Parman; P Oflazer; F Deymeer; G Saruhan-Direskeneli
Journal:  Clin Exp Immunol       Date:  2017-07-28       Impact factor: 4.330

4.  Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.

Authors:  Vuslat Yilmaz; Piraye Oflazer; Fikret Aysal; Hacer Durmus; Kostas Poulas; Sibel P Yentur; Yesim Gulsen-Parman; Socrates Tzartos; Alexander Marx; Erdem Tuzun; Feza Deymeer; Güher Saruhan-Direskeneli
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

5.  Identification of the Regulatory Role of lncRNA SNHG16 in Myasthenia Gravis by Constructing a Competing Endogenous RNA Network.

Authors:  Jianjian Wang; Yuze Cao; Xiaoyu Lu; Xiaolong Wang; Xiaotong Kong; Chunrui Bo; Shuang Li; Ming Bai; Yang Jiao; Hongyu Gao; Xiuhua Yao; Shangwei Ning; Lihua Wang; Huixue Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-18       Impact factor: 8.886

6.  A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis.

Authors:  Sapna Sharma; Clas Malmeström; Christopher Lindberg; Sarah Meisel; Karin Schön; Martina Verolin; Nils Yngve Lycke
Journal:  Front Immunol       Date:  2017-10-24       Impact factor: 7.561

7.  Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy.

Authors:  Wenhua Xu; Mingshan Ren; Swagata Ghosh; Kai Qian; Zhaofeng Luo; Aimei Zhang; Cuiping Zhang; Jiajun Cui
Journal:  Mediators Inflamm       Date:  2020-02-14       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.